Renal Cell Carcinoma — Trials

Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,621 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 375
Recruiting: 193
Ph III recruiting: 14
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (276)

clinicaltrialsPublishedShowing 651–681 of 681 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00065572	Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)	suspended	Phase 2	—	AstraZenecaINDUSTRY	1	Jan 26, 2011	clinicaltrials
NCT01240005	Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma	unknown	Phase 1 / Phase 2	30	Qingdao UniversityOTHER	1	Nov 15, 2010	clinicaltrials